237 related articles for article (PubMed ID: 27196750)
1. Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma.
Amodio N; Stamato MA; Gullà AM; Morelli E; Romeo E; Raimondi L; Pitari MR; Ferrandino I; Misso G; Caraglia M; Perrotta I; Neri A; Fulciniti M; Rolfo C; Anderson KC; Munshi NC; Tagliaferri P; Tassone P
Mol Cancer Ther; 2016 Jun; 15(6):1364-75. PubMed ID: 27196750
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA TUG1 promotes proliferation and inhibits apoptosis in multiple myeloma by inhibiting miR-29b-3p.
Liu D; Wang J; Liu M
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30842339
[No Abstract] [Full Text] [Related]
3. miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1.
Amodio N; Di Martino MT; Foresta U; Leone E; Lionetti M; Leotta M; Gullà AM; Pitari MR; Conforti F; Rossi M; Agosti V; Fulciniti M; Misso G; Morabito F; Ferrarini M; Neri A; Caraglia M; Munshi NC; Anderson KC; Tagliaferri P; Tassone P
Cell Death Dis; 2012 Nov; 3(11):e436. PubMed ID: 23190608
[TBL] [Abstract][Full Text] [Related]
4. HDAC4 Knockdown Induces Preeclampsia Cell Autophagy and Apoptosis by miR-29b.
Du J; Ji Q; Dong L; Meng Y; Xin G
Reprod Sci; 2021 Feb; 28(2):334-342. PubMed ID: 32780359
[TBL] [Abstract][Full Text] [Related]
5.
Wu H; Liu C; Yang Q; Xin C; Du J; Sun F; Zhou L
Autophagy; 2020 Apr; 16(4):683-697. PubMed ID: 31242129
[TBL] [Abstract][Full Text] [Related]
6. miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells.
Amodio N; Bellizzi D; Leotta M; Raimondi L; Biamonte L; D'Aquila P; Di Martino MT; Calimeri T; Rossi M; Lionetti M; Leone E; Passarino G; Neri A; Giordano A; Tagliaferri P; Tassone P
Cell Cycle; 2013 Dec; 12(23):3650-62. PubMed ID: 24091729
[TBL] [Abstract][Full Text] [Related]
7. MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib.
Jagannathan S; Vad N; Vallabhapurapu S; Vallabhapurapu S; Anderson KC; Driscoll JJ
Leukemia; 2015 Mar; 29(3):727-38. PubMed ID: 25234165
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma.
Stamato MA; Juli G; Romeo E; Ronchetti D; Arbitrio M; Caracciolo D; Neri A; Tagliaferri P; Tassone P; Amodio N
Oncotarget; 2017 Dec; 8(63):106527-106537. PubMed ID: 29290968
[TBL] [Abstract][Full Text] [Related]
9. miR-29b inhibits the progression of multiple myeloma through downregulating FOXP1.
Wang H; Ding Q; Wang M; Guo M; Zhao Q
Hematology; 2019 Dec; 24(1):32-38. PubMed ID: 30068241
[TBL] [Abstract][Full Text] [Related]
10. Lnc NEAT1/miR-29b-3p/Sp1 form a positive feedback loop and modulate bortezomib resistance in human multiple myeloma cells.
Che F; Ye X; Wang Y; Ma S; Wang X
Eur J Pharmacol; 2021 Jan; 891():173752. PubMed ID: 33253679
[TBL] [Abstract][Full Text] [Related]
11. miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma.
Yang Y; Li F; Saha MN; Abdi J; Qiu L; Chang H
Clin Cancer Res; 2015 May; 21(10):2399-411. PubMed ID: 25724519
[TBL] [Abstract][Full Text] [Related]
12. LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p.
Pan Y; Zhang Y; Liu W; Huang Y; Shen X; Jing R; Pu J; Wang X; Ju S; Cong H; Chen H
Cell Death Dis; 2019 Feb; 10(2):106. PubMed ID: 30728351
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1.
Zhang YK; Wang H; Leng Y; Li ZL; Yang YF; Xiao FJ; Li QF; Chen XQ; Wang LS
Biochem Biophys Res Commun; 2011 Oct; 414(1):233-9. PubMed ID: 21951844
[TBL] [Abstract][Full Text] [Related]
14. Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.
Zhang X; Chen X; Lin J; Lwin T; Wright G; Moscinski LC; Dalton WS; Seto E; Wright K; Sotomayor E; Tao J
Oncogene; 2012 Jun; 31(24):3002-3008. PubMed ID: 22002311
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia.
Sampath D; Liu C; Vasan K; Sulda M; Puduvalli VK; Wierda WG; Keating MJ
Blood; 2012 Feb; 119(5):1162-72. PubMed ID: 22096249
[TBL] [Abstract][Full Text] [Related]
16. DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma.
Amodio N; Leotta M; Bellizzi D; Di Martino MT; D'Aquila P; Lionetti M; Fabiani F; Leone E; Gullà AM; Passarino G; Caraglia M; Negrini M; Neri A; Giordano A; Tagliaferri P; Tassone P
Oncotarget; 2012 Oct; 3(10):1246-58. PubMed ID: 23100393
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibition regulates miR-449a levels in skeletal muscle cells.
Poddar S; Kesharwani D; Datta M
Epigenetics; 2016 Aug; 11(8):579-87. PubMed ID: 27184529
[TBL] [Abstract][Full Text] [Related]
18. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
[TBL] [Abstract][Full Text] [Related]
19. The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma.
Yuan JH; Yang F; Chen BF; Lu Z; Huo XS; Zhou WP; Wang F; Sun SH
Hepatology; 2011 Dec; 54(6):2025-35. PubMed ID: 21837748
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of miR-335 induces migration by targeting insulin-like growth factor-1 receptor in multiple myeloma.
Qi J; Shi LY; Wu Y; Shen XJ; Yuan J; Jin CJ; Cong H; Ju SQ
Leuk Lymphoma; 2019 Dec; 60(13):3188-3198. PubMed ID: 31190579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]